**[미래에셋 제약/바이오 김승민]**
**9/29 Daily**

[https://t.me/bioksm](https://t.me/bioksm)


 **글로벌 바이오/제약**
────────────────────
 [머크, scibrunch 암 치료제 라이선스 계약 체결, 최대 21억 3천만 달러 규모](https://news.google.com/rss/articles/CBMitgFBVV95cUxQNDdBQWp0eXhySGlJdTloSFcwMVk1WmY1NzVlZldsRDZRTjRRdy0zTHVCbXU5QjRlSWdFWmI2OGNXNmN6SHp2dF9oOEItN1E2dl9kSnZjZVYwT096T1V0aUpvT0pzX29aWVhILVBLMDdZMkRQX2VsZHBrRUJuT3phY1MzQ2Rlcy12OEZWTm9XWG12YmZDVkI1cU1ObWtzNzJOcEN1MklZZ2dQWWxMRGJMQThLZFdFZw?oc=5)

 [바이오엔텍, 구매자 부재로 독일 3개 시설 폐쇄](https://news.google.com/rss/articles/CBMiyAFBVV95cUxPWXFZMGZ3dGZNR2l2TXZxcHhWN1dPeWVXLVJwY0tHYVBSSl93c09MOFUzQjlDN2dldnNzOUVYNEI2LXpXYzVsNlo2bW41dWFXdE5MNGVVY1pvNUpaYnhJZm5wa1dIa1NHeU8ydmhkSFota3U1SE1ZZlNvU2N0SVExbFRNWFd0cklUMTdwU1VMZWRBRF9fVTdIN3pxTWVnUFd4R0RjOEJBOWt5c2h3RXpDTnYtdmlnQXJWZVljaER1NTktdTd1SW9MaA?oc=5)

 [미국 제약사, 중국과의 라이선스 딜로 방향 전환](https://news.google.com/rss/articles/CBMimAFBVV95cUxQWkJGbFUwTzg3ZWQ5OUxVcjR0MzN0NXhSRmk3Ukh4RFFkRkF3bFFKOGMtQzZ5WGVYNUlNSmE1Y0pKa01mSHp4ZWdqT0Q0Nkh1ZGl3cHZuZlNVang0aHEyeENsVGdfdDhOSmY5aE1DNlVPdWloQm5Gb182WmZrallZYjI5NDdQbVNENmQwVnZGWmhMMjJZQ09xWQ?oc=5)

 [릴리, 저소득·중간소득국 당뇨병·비만 치료 격차 해소 목표 "Change the Course Commitment" 출범 - Press Release](https://investor.lilly.com/news-releases/news-release-details/lilly-launches-lilly-change-course-commitment-aiming-address)

 [아스트라제네카, 싱가포르 ADC 항암제 시설에 800명 이상 신규 채용 - 싱가포르 경제개발청](https://news.google.com/rss/articles/CBMi2wFBVV95cUxPem8ydHJQQnB1TGw1RkZMbXktN1F3UlJIc25xM3JCN0tHQzBxclZFNWZfamctZHIwZTZ6UnhUX3NZMDRKcHhSLWppcFlIZGNXeFd6djczVFJhaUN5ak5qTi1SME9vVlVORWcxZ3I2ZF9HS3I4ejd6N3lxaDBRN3p3YThBc0FnWUpCQkJDRjhMSVc4VTV3MFlhTXlKYjhkUGVnVlFyWnIwS3VVMWZEVnRlMFlBYUROVXpjcXhIU2YzeEU5d190bXd3SGdRNWk4bXoyMWhQdll6YkRDTmM?oc=5)


 **한국 바이오/제약**
────────────────────
[️ 담관암 신약 FDA 승인에 HLB 계열사 잇따라 '상한가](https://www.hitnews.co.kr/news/articleView.html?idxno=79459)'

 [알지노믹스 RZ-001, EMA 희귀의약품 지정 권고 획득](https://www.hitnews.co.kr/news/articleView.html?idxno=79418)

 [리가켐 협력사 소티오 ADC, 美 FDA 희귀의약품 지정](https://news.google.com/rss/articles/CBMibkFVX3lxTFBlQm0tcWY5eUl2UUg2R0o5S0c4TzJIX29aZ3ozSzZzcmNENHNDencyQ2ZhU2VHZGdyRE55djA0aVNWQXlrcjZLRjBqemRtVTBOOEI0MG1Vcm5qWTItd2R5SFRHUFlhRjFhZkZYb2h3?oc=5)

 [대웅제약, AI 기반 방출조절·복합제형 설계 국책과제 주관](https://www.hitnews.co.kr/news/articleView.html?idxno=79423)

 [유한양행에게 던져진 질문은 '다음 사장'에 앞서 '다음 성장 방식](https://www.hitnews.co.kr/news/articleView.html?idxno=79382)'

 [메디톡스, 히알루론산 필러 ‘뉴라미스 볼륨 리도카인’ 중국 품목허가 획득 - 한국경제](https://news.google.com/rss/articles/CBMiWkFVX3lxTE9QZ2xxZ3B5bXhicjlyc1QzM01NQXZNV3Fpemk0d1phTm1vNGxMUkI3QUR0ZUg2ZWZHcmtpOFN2b0dtd1BNVERQN0J0bTFFX3pjZnR2dHJJell4dw?oc=5)

 [삼성바이오로직스, 2026 BPI서 바이오의약품 제조 공정 혁신 공개](https://news.google.com/rss/articles/CBMiWkFVX3lxTE5mU2VNWm53QjBXUWQ2MVY1U1F3YjVmRUJpc2tNMlNlY3Y2d1M2VFdCdHhHOUdpdTkwOUJvVWg5S3F0S2tLLXdUQU00YVIyUkNHZU13bmFta0dtdw?oc=5)

 [치매치료 시장 '1000억' 넘어섰다, 그 중심에 선 혁신신약 '레켐비](https://www.hitnews.co.kr/news/articleView.html?idxno=79380)'

 [온코닉테라퓨틱스, 미공개 비만 신약후보 11월 첫 공개](https://www.hitnews.co.kr/news/articleView.html?idxno=79422)


────────────────────